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I will begin by telling a little about 
the development of chronic dialysis. In 
1959 we were working on a system to 
prevent uremia in acute renal failure. 
We were trying to develop a system to 
which we could "hook" the patient 
for as Jong as a week, so that we would 
exactly mimic his normal kidney func-
tion during the period of acute renal 
failure, and make his prognosis that 
of a patient who had kidneys. The 
system worked reasonably well. We 
had to make a lot of modifications, 
such as using a Skeggs-Leonard dia-
lyzer with low resistance. We used a 
large deep freeze as a dialysate reser-
voir because we could not afford to 
change the bath every few hours. The 
patient was on continuously. We had 
to cool the external circuit to control 
clotting problems and infection. We 
actually had patients on this system for 
as long as two weeks. It was important 
to us that we had this system in opera-
tion at the time we first devised the 
cannulas. (The cannulas were devised 
by Dr. David Dillard, our surgical con-
sultant, and Mr. Wayne Quinton. It is 
amazing how well their original design 
has held. As far as I know, it has not 
been improved greatly, because the can-
nulas are still the weakest part of the 
system.) 
General Features of the Cannulas and 
Shunt 
The essential system has a long sub-
cutaneous tunnel with a curve of 180° 
into each vessel. The tunnel is to pre-
vent infection, and the curve is to 
stabilize the cannula in the vessel. The 
system does not clot because one tube 
is in the artery and one tube is in the 
vein, and the blood runs through. Of 
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course, it all depends on tefion for 
non-clotting. Allwall had tried the idea 
in 1944 and failed, because he was 
using glass cannulas and rubber tub-
ing; we had a tefion system exclusively. 
This is the basic operating principle 
of the system: when you want to treat 
a patient, you simply pull off the shunt, 
connect the tubing to the artificial kid-
ney, and you can dialyze at will. The 
best evidence I can give that this sys-
tem works is the first chronic patient 
ever to receive cannulas. He is Clyde 
Shields, who now has been five-and-
one-half years on dialysis. He has not 
passed any urine in over five years, 
and is today in better health than at 
any time. We had to learn on our first 
patients how to manage chronic uremia 
by dialysis. We did not know how 
much dialysis it would take, we did 
not know how to take care of the 
cannulas, and we did not know what 
complications to expect. Clyde has his 
present cannulas in his leg. We used 
up all the arm sites in the first few 
months because the straight tefion 
system would last only a few months 
and not much longer. The new rubber 
segment has made a great difference in 
the cannula system. The nurse used 
to put the heparin into the blood-
stream. We no longer do this, but use 
an infusion pump. Note, though, that 
the nurse does the entire procedure. 
In Seattle, dialysis is completely nurse-
technician operated on the chronic 
program, and doctors are not in at-
tendance. 
We had our clear plastic Kiil dia-
lyzer built especially to study dialyzer-
fiow pattern. One of the things that is 
so important is a better understanding 
of what is going across these mem-
branes. If we could really understand 
what the chemicals are that we had to 
move, and urea is one of them, then 
we could build better membranes. As 
far as the technique of dialyzer de-
sign, ours is a good one but it is not 
perfect. There is streaming, and the 
minute you get streaming in a dialyzer, 
you loose efficiency. We had this par-
ticular version built to study the flow 
patterns. This Kiil dialyzer is the de-
sign of Dr. Frederick Kiil in Oslo. He 
took the original Skeggs design and 
modified it so that it was easier to as-
semble, and more efficient to use. This 
is the only dialyzer at the present time 
that has been proven useful in the 
treatment of chronics, because it is low 
in resistance, small in blood volume, 
and easy to assemble. When the blood 
finally reaches the venous end of the 
external circuit, the nurse plugs the 
venous candula in and the patient is on 
dialysis. 
For some idea of the progress being 
made in the technology, where we 
could formerly only treat three pa-
tients, we can now take four, thanks 
to the central pumping system which 
takes concentrate from a tank, and uses 
very accurate proportioning pumps. 
They mix the concentrate with tap 
water, which is monitored by a conduc-
tivity meter, and then the fluid is 
pumped around the room to the vari-
ous stations. The whole system is auto-
matic. This then means that we fill 
this concentrate tank about once a 
month instead of filling a tank once a 
day for each patient. 
Results of Management by Dialysis 
We recently conducted a survey on 
the current state of dialysis around the 
world. There are 12 centers that have 
been in operation for longer than one-
and-one-half years. There are seven, 
and probably more, newer groups just 
getting started. There have been 95 
patients taken into treatment. There 
have been 28 deaths. What is most im-
portant is that 75 % of the deaths have 
occurred during the first year of each 
program. This underscores the need 
for adequate preparation, adequate 
funding, adequate training of person-
nel, and adequate creation of facilities 
especially for chronic dialysis . This 
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also means that a realistic approach to 
the problem is needed, rather than the 
helter-skelter one that is so tempting 
when you are confronted with a dying 
patient. The other 25 % of the deaths 
were due to what we considered to be 
natural causes. In other words, the 
one patient who died in Seattle, died 
one year after starting the program, of 
a myocardial infarction. And we cer-
tainly do not believe that dialysis is 
going to prevent myocardial infarction. 
In fact , these patients having only 
moderately good control of their blood 
pressures (some have normal and some 
have moderate elevation of blood pres-
sures), obviously are going to be more 
prone to the vascular complications of 
hypertension than the normal popula-
tion. But these deaths are the natural 
ones, and the other deaths can virtually 
be eliminated with proper training and 
proper preparation. 
The rehabilitation rate should also 
increase as treatment is started earlier, 
so you will not be dealing with mori-
bund patients. A lot of the failure to 
rehabilitate has been due, for instance, 
to starting with a moribund patient 
who gets severe neuropathy. This has 
been the case in our one failure to re-
habilitate, and an early start would 
avoid this. As far as prognosis is con-
cerned, the longest one is our patient 
who has been five-and-one-half years 
on dialysis. He is in better health now 
than he has been at any time. 
Limitations of Dialysis in Children 
If you take the ideal group, dialysis 
seems to be contraindicated currently 
in the adolescent and the child, because 
we have failed to maintain normal 
growth and to effect sexual maturity in 
the one patient we treated in this way 
in Seattle. This does not mean that, with 
improved membranes and improved 
techniques, we will not be able to main-
tain normal growth. And this will be 
a very sensitive assay of the adequacy 
of dialysis. Even when confining our-
selves to the age group of 15 to 45, we 
have about 25 new patients per one 
million population per year. In the 
United States, there are about 5,000 
new patients per year. If the life ex-
pectancy is 10 years, this means there 
will be a patient population of 50,000. 
This is indeed a staggering number of 
patients. When we think of our present 
technology, no wonder adequate treat-
ment seems impossible. On the other 
hand, I think we are just scratching the 
surface of what is possible technically, 
and I would like to underscore that by 
briefly covering some of the advances 
made since the program began. 
Problems and Complications 
The first problem we faced was loss 
of the cannulas. Mr. Quinton correctly 
diagnosed the reason as due to stiffness 
in the teflon. The system would not 
give with the normal rotation of the 
limb, and we lost the cannulas in a 
matter of months due to mechanical 
failure. Infection has occurred, of 
course, but it is largely due to abuse 
of the cannulas by the patient, and 
inability to cooperate in his daily care. 
Mr. Quinton worked one year to ex-
trude silicone rubber tubing that would 
not clot, after Dow-Corning said that 
it could not be done. Now all patients 
on chronic dialysis have this shock ab-
sorber in the system which greatly 
prolongs the life of the cannulas. The 
first patient to get this kind of can-
nula was in the program in Seattle, and , 
three years later, he has the original 
set. The usual life of these cannulas 
extends from a few months to one-and-
one-half years, depending, mainly, on 
how carefully the patient takes care of 
his cannulated extremity. Certainly, 
undue activity is the most important 
factor in determining cannula failure. 
We think the flexibility primarily ac-
counts for the increased longevity of 
the cannulas, compared with the old 
teflon. 
In Seattle, as in most centers, dial-
ysis worked like this: it was an op-
erating room procedure that took a 
lot of work, a lot of people, and was 
terribly expensive. Chronic dialysis 
twice a week, using this approach, cost 
from $20,000 to $30,000 per patient 
per year. But in two years, starting with 
the basic continuous system I men-
tioned, we have evolved the Seattle 
continuous-flow, low-temperature sys-
tem. We have turned it into a nursing 
procedure. This makes possible, then, 
the Seattle community center-type op-
eration (under the direction of John 
Murray, first, and now Jerry Pendras), 
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where one nurse dialyses four patients 
at once. The cost projections and the 
pattern of operation of chronic dial-
ysis all depend on the basic lessons 
learned in this center, which was very 
generously and very wisely funded by 
the John A. Hartford Foundation in 
1962. This center was built in the 
basement of the nurses' home in Swed-
ish Hospital. It shows what could be 
done in the community, and that it 
could be done outside the hospital or in 
a low cost area. The cost of this type of 
operation currently is $100 per dialysis, 
or $10,000 per year for two treat-
ments per week, including professional 
fees. This is really the actual, total 
cost. Rule off something such as con-
struction and purchase of fixed equip-
ment, and the cost is somewhat less. 
We have made considerable progress 
in understanding the diseases of dialy-
sis. Clearly, all of these diseases, with 
the exception of peripheral neuropa-
thy, are due to inadequate dialysis. 
The experience of the older days, 
where you could not dialyze as much 
as necessary, or the patients lost 
weight, vomited, became malnourished, 
and died, was simply because of in-
adequate dialysis. Gout, or gouty-like 
arthritis which is an acute arthritis that 
is responsive to colchicine and can be 
reproduced by putting urate in the 
bath, responds to adequate dialysis. 
Metastatic calcifications dissolve if you 
keep the phosphorous low enough with 
dialysis, and peripheral neuropathy can 
be stabilized by dialysis. But probably 
the most important factor in peripheral 
neuropathy in these patients is the 
critical illness that may precede the 
institution of therapy. Invariably, if 
the patient becomes critically ill at the 
time you start therapy, in a week or a 
month he may develop a severe periph-
eral neuropathy. The degree of se-
verity of this neuropathy varies tre-
mendously from patient to patient, but 
the clinical picture is constant. There 
is now an excellent description of this 
situation in the literature from the 
Massachusetts General Hospital. The 
prevention of neuropathy at this stage 
of our understanding depends largely 
on starting dialysis or doing the trans-
plant before you are dealing with a 
moribund patient. We have not yet 
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defined diseases due to much dialysis, 
but because our membrane is non-
specific, I am sure that some will be 
defined. Secondary hyperparathyroid-
ism is not a problem, but anemia is a 
continuing problem. The average re-
quirement, if you rinse your dialyzer 
properly, is about two units of blood 
per month. This is an area of obviously 
great interest. If an erythropoetin could 
be made available, we might eliminate 
this. Stanley Sheldon in London be-
lieves that more intense dialysis and a 
higher protein diet will minimize the 
anemia. 
The greatest problem for the patient 
is controlled hypertension. The real 
cross these patients must bear is learn-
ing to eat a low-salt diet. There is no 
question that if he can learn a low-salt 
diet, his blood pressure will be con-
trolled. It takes from three to six 
months for a patient to really learn to 
eat a low-salt diet. They cannot cheat. 
If they eat salt, they gain weight, and 
it shows up on the scale when they 
come into the center. Once they learn 
it, their pressures are controlled either 
at, or near, the normal level. 
The Future of Hemodialysis 
With this background, then, I am 
going to talk briefly about my concept 
of the future of management of 
chronic uremia. One point I want to 
make here is about good conserva-
tive care. This is an area which is 
greatly misunderstood, both by ne-
phrologists and by doctors in general. 
The most important factor we have 
found in the management of the 
chronic is the control of hypertension 
by means of sodium restriction. All 
the emphasis in the literature on the 
management of the chronic has been 
on the salt-losing crisis and the magic 
effects that salt has on a patient in 
uremia. This is not the place to put 
the emphasis. There is no question 
that, if a patient is salt-depleted, and 
his neck veins are flat and his blood 
pressure is down, that his GFR will 
drop almost to zero. Salt, then, can 
have a miraculous, life-saving effect on 
this patient. But for every one of these, 
there are 500 patients who are being 
abused by too much sodium. It is our 
contention that it is the high blood 
pressure induced by sodium overload, 
rather than the disease itself, that is 
most often responsible for progression 
of the renal lesion to the fatal end. And 
we have diagrammed this idea by 
showing the maximum and a minimum 
sodium excretion for a patient having 
progressive loss of his kidney function 
over a 30-year period. At some point, 
he gets both a floor and a ceiling on 
this ability to handle sodium. The ina-
bility to conserve sodium has gotten 
all the emphasis because a few patients, 
particularly those with pyelonephritis 
and polycystic disease, waste sodium. 
But as of now in our renal clinic, we 
have about 30 chronics with serum 
creatinines above 2, and there is only 
one that is a significant salt waster. The 
more important problem is that they 
have an upper limit on their ability to 
excrete sodium and when they start 
taking in more than they can handle, 
their blood pressure rises, they get 
malignant hypertension, and die. We 
give every patient a blue book to re-
cord his blood pressure, weight, and 
urine volume, although the urine vol-
ume is not really important. Then we 
teach them the relationship between 
the amount of salt they eat, the change 
in their weights, and the change in 
their blood pressures. We saw a pa-
tient in 1960 who had "bad hyper-
tension". The sole maneuver there was 
to put him on sodium restriction. True, 
his creatinine bounded around a little. 
When first started, the creatinine will 
always go up, which is another thing 
that has received undue emphasis. As 
long as it does not go up into the 
symptomatic range, you should not 
care. Because, if you are not going to 
control that blood pressure, experience 
shows that the man will be dead in a 
matter of months. Four years later, 
this patient's creatinine is still stable 
around 8 and his blood pressure is well 
controlled on a low salt diet. Occasion-
ally it is well to add small doses of 
blocking agents, but our experience 
shows that patients with uremia toler-
ate these drugs very poorly. If they go 
into dialysis, they are going to have to 
go on a low salt diet anyway. We pre-
fer to use the diet as our major thera-
peutic tool. All of our patients, we 
feel, would have been dead within 
months had their blood pressures not 
been controlled. So the message is, 
control blood pressure by any means 
that you can , and you are likely to get 
a lot more mi leage out of your patient 's 
kidneys and avoid the day when defini-
tive therapy is going to be needed. I am 
not minimizing the importance of giv-
ing salt if the patient is sodium de-
pleted, but this is a very special, rare 
problem. What I am talking about is 
the garden-variety, day-to-day manage-
ment of the patient with renal insuf-
ficiency. 
The Place of Peritoneal Dialysi> 
Dr. Fred Bohn has been working in 
peritoneal dialysis for a number of 
years, and his monograph is well 
known. Eighteen months ago, perito-
neal dialysis in the management of the 
chronic was discredited, and rightly 
so, because peritonitis was the rule. 
Dr. Bohn devised an automatic cy-
cling machine; which is a completely 
closed dialysate system. He figured out 
an experiment to sterilize these big 
bottles of fluid so that no one has to 
cycle the machine, thereby eliminat-
ing the need of the nurse or family. 
Now, after having lost one patient with 
peritonitis, he has a second patient go-
ing, and believes it is because of this 
closed system which maintains sterility. 
After three months of treating this 
patient for recurrent peritonitis, he 
resolved that the indwelling peritoneal 
access prosthesis was the villain, and 
to make a successful chronic perito-
neal dialysis, he had to insert a perito-
neal cannula every week, through a 
tiny incision that heals from one week 
to the next. Since he removed the 
prosthesis, he has not had a bit of 
trouble with peritonitis. It is on the 
basis of comparing the patient who 
loses significant amounts of protein 
through the peritoneal membrane with 
our patient on hemodialysis, that we 
think that a synthetic membrane with 
a larger pore size is needed. 
Hemodialysis in Relation to Transplan-
tation 
We are very concerned about the 
future of dialysis in relation to the real 
hope in this field, transplantation. 
There is no question that if you have 
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a human kidney inside you, working, 
this is far superior to an artificial one. 
You are not tied to a machine, you 
don't have to worry about getting to 
the center, you don't have to take care 
of cannulas, and you don't have to eat 
a low salt diet. But as we see them, 
here are the facts on the current status 
of transplantation: Of the identical 
twins whose operations were per-
formed five years ago, 70% are now 
dead of recurrent kidney disease. The 
recurrence rate is 50% in the Boston 
group. We had a patient with glomeru-
lar nephritis who was sent to the Mayo 
Clinic and transplanted from her 
mother. Six days after the transplant, 
the mother's kidney was destroyed by 
the same disease that originally had 
destroyed the patient's kidneys. This 
is a very important case, of course. A 
question raised is, had this patient 
been carried for two or three years 
on chronic dialysis, would this im-
mune activity have abated and would, 
then, the transplanted kidney have sur-
vived? If we get another such patient, 
we will try a double transplant, proba-
bly first from a cadaver, doing it right 
away, and then waiting two or three 
years and trying it a second time. Dr. 
Don Thomas, who is in charge of our 
transplant program, recently reviewed 
the latest summary from Dr. Joe Mur-
ray's group in Boston. He concluded 
that the chances of surviving for two 
years on a transplanted kidney are 
somewhere between 5 and 20% . The 
chances of surviving for four years 
probably are less than 1 % . 
I can say with some conviction that 
the chance of surviving four years on 
chronic dialysis in the current well-run 
program approaches 100%. The big if 
in the dialysis program is that you 
must have a cooperative patient. The 
one thing stressed by all now doing 
chronic dialysis is, if the p,atient can-
not cooperate, take care bf his can-
nulas, or stay on the low salt diet, 
then the chronic dialysis is not a very 
good form of treatment. The amazing 
thing we have found is that a group 
of patients who are cooperating seem 
to pull along the ones who are not, 
especially during the early days when 
they are learning about the program. 
Most patients will cooperate, because 
when they begin to feel well and see 
what salt overload does to them, they 
learn from bitter experience that it is 
better to cooperate than to be sick. 
I want to make another point that 
I believe is important because of the 
neuropathy problem. Despite eco-
nomics and the intense need right now, 
the sooner we make a logical transition 
from good pre-dialysis care into dialy-
sis, and into transplant after dialysis 
without having a crisis, the sooner our 
patients are going to be happier. Our 
new clinic that will be opened at Swed-
ish Hospital has the capacity for 30 
new patients. Our patients who now 
are being treated in town by the vari-
ous kidney doctors have ·already vis-
ited the center. They know what they 
are going to get into when the day 
comes. They have heard about trans-
plants, they are prepared emotionally, 
and they are getting prepared finan-
cially to take on the definitive treat-
ment, long before it will be necessary. 
This is an ideal that we are far from 
achieving. When we do achieve it, our 
patients and doctors will be much 
happier. 
Home Dialysis 
So the hope for the future rests on 
lowering the cost of the present form 
of treatment (the central pumping sys-
tem is one example of how we are do-
ing this with the important cooperation 
of our engineering colleagues), some 
form of home dialysis, and, of course, 
the big hope is that we can make real 
progress in the immunology of trans-
plantation. Now we have a very ex-
citing development, one that I think 
offers real hope, particularly in the 
financial area. That is home dialysis. 
Our first patient on the home program 
was a young high school girl who is 
dialysed by our family in her basement. 
The dialyser is a miniaturized version 
of our central pumping system that is 
fully automated. A standard Kiil dialy-
ser is used. We switched from zepharin 
or formaldehyde to acetic acid, a more 
effective germicide that is often for-
gotten. When using acetic acid to 
sterilize the artificial kidney, some is 
left in, which the patient readily me-
tabolizes. Then, when ready to dialyze, 
you simply hook the kidney to the bath 
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source, acetic acid becomes sodium 
acetate, and you convert a germicide 
into a metabolizable substance. Then, 
as I mentioned, the dialysis fluid is 
supplied by a miniaturized version of 
our central pumping system or by a 
home tank. 
We started the patients in an isolated 
area of the hospital, where the family 
can be taught a little about what goes 
on inside an artificial kidney. The fam-
ily first observes the technique and 
gradually begins to take over. It takes 
a surprisingly short time to teach a 
family to operate a system at home. 
We totally underrated the motivation 
of the patient to learn. The family 
realizes it is their relative's life at stake, 
and that if they do not learn to run the 
equipment, they might well lose their 
relative. They learn much faster than 
our technicians and nurses who train 
for our center program. 
We are literally just scratching the 
surface on what is going to be possible 
in the home program. The cost, which 
we hope is generous, looks like it is 
going to be under $5 ,000 per year. The 
breakdown is very encouraging, be-
cause such things as equipment, main-
tenance, and depreciation are the kind 
of things communities can fund. This 
leaves $3,000 or so per year for the 
patient to pay. The startup costs are 
around $8,500 for the first year. This 
is a very rough figure; we do not have 
enough experience with home dialysis 
to know, but at least it is less than 
half of what our current center type 
of operation costs. (As of November 
1965, there are seven patients on home 
dialysis in Seattle, and there have been 
no failures.) 
The advantages of home dialysis, 
in addition to the cost factor, is more 
intensive dialysis. It can be done in the 
evening, for example. Instead of spend-
ing the evening in the center, they 
spend the evening at home. When an 
unattended nighttime dialysis is possi-
ble, we have 56 hours a week during 
the night to dialyze. This would then 
free all of the patient's waking hours 
for normal activities. A very important 
point psychologically, is that the patient 
himself becomes responsible for the 
care instead of the institution. There is 
a real feeling of independence. 
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Frequent short dialyses are more 
effective. On twice-weekly dialysis, for 
a total of 20 hours per week, the pa-
tient's creatinine got up to 12. On 
three times per week, for a total of 18 
hours or less time per week, his 
creatinine got up to 10. So this kind of 
study projects that the frequent short 
dialyses are going to keep these pa-
tients much healthier than the infre-
quent, prolonged dialyses can. 
One problem is that not everybody 
is going to be able to go home. We 
estimate, in our present population 
of about 20 patients in Seattle, that 
only half are going to go home. There 
are going to be other solutions, but 
the home program is the ultimate one. 
The center type is perfectly satisfactory 
if you can afford it, and something in 
between may be the answer for other 
patients. Maybe you can get them to-
gether in an apartment home-"You 
dialyze me tonight and I'll dialyze you 
tomorrow night"-This sounds crazy 
but it will be necessary if people are 
going to survive within the economic 
limits we can provide. 
